QuadVantage Technology
Early Stage
Transforming ACL Reconstruction Surgery
Overview
Raised: $295,750
Total Commitments ($USD)
Platform
Dealmaker Securities
Start Date
08/07/2022
Close Date
04/10/2023
Min. Goal
$25,000
Max. Goal
$5,000,000
Min. Investment
$500
Security Type
Equity - Preferred
Series
Seed
SEC Filing Type
RegCF
Price Per Share
$2.50
Pre-Money Valuation
$9,800,000
Rolling Commitments ($USD)
Status
Funded
Reporting Date
04/29/2023
Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise
$1,207
# of Investors
20
Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded
2018
Industry
Healthcare & Pharmaceuticals
Tech Sector
HealthTech
Distribution Model
B2B
Margin
Low
Capital Intensity
High
QuadVantage Technology is raising funds on Dealmaker Securities. The company is transforming ACL reconstruction surgery with its QuadVantage Autograft System. The QuadVantage Quadriceps Autograft System makes the harvesting of Quadriceps tendon easier, more precise, less painful, and less traumatic. QuadVantage’s technology is clinically tested and has received FDA approvals. The technology helps to eliminate guesswork, leaves only a small scar, and costs less compared to competitors. Thomas Gutierrez founded QuadVantage Technology in October 2018. The current crowdfunding campaign has a minimum target of $25,000 and a maximum target of $5,000,000. The campaign proceeds will be used for growth and expansion.
Summary Profit and Loss Statement
| Most Recent Year | Prior Year | |
|---|---|---|
|
Revenue |
$0 |
$0 |
|
COGS |
$0 |
$0 |
|
Tax |
$670 |
$20 |
| ||
| ||
|
Net Income |
$-1,222,273 |
$-536,739 |
Summary Balance Sheet
| Most Recent Year | Prior Year | |
|---|---|---|
|
Cash |
$6,943 |
$3,829 |
|
Accounts Receivable |
$0 |
$0 |
|
Total Assets |
$25,166 |
$197,555 |
|
Short-Term Debt |
$1,796,792 |
$599,901 |
|
Long-Term Debt |
$204,617 |
$556,234 |
|
Total Liabilities |
$2,001,409 |
$1,156,135 |
Financials as of: 08/07/2022
Create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Already a member? Log in here.
Ratings 
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.